Virus-like particles as a practical alternative to cultured rubella virus

Virus-like particles (VLPs) are revolutionizing the fields of diagnostics and immunization. These non-infectious structures mimic the surface of native viruses, offering a safe and effective platform for antibody detection and vaccine development.

This whitepaper explores the growing importance of VLPs in advancing the diagnosis and prevention of infectious diseases, with a particular focus on rubella. It covers the evolution of virology, the production and mechanisms of VLPs, and their significant role in research and diagnostics.